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Abstract 
The three-dimensional structure of the two hepatotoxic microcystins LR and LY has been determined by two-dimensional nuclear magnetic 
resonance (2D NMR) spectroscopy and distance geometry calculations. For the microcystin LY a single family of highly convergent structures was 
obtained. This family is characterized by a relatively compact boat-like ring structure with the large side chain of the Adda residue protruding from 
the concave side, in close proximity to the Tyr side chain. Conversely, for the microcystin LR the calculations result in three conformational families 
characterized by an even more compact ring structure. The Adda and Arg side chains protrude from the ring distal from one another caused by the 
repulsion between the guanido function of Arg and the hydrophobic Adda. The lower toxicity of the LY microcystin could result from the restricted 
access of the Adda side chain, an essential residue for activity, which results from the close proximity of the aromatic Tyr residue. A significant 
enthalpic cost would be expected for disturbance of this hydrophobic collapse and correspondingly lower binding affinity to receptor molecules would 
be predicted. From the structures of the two related microcystins, and homology with other known toxins, we propose a working hypothesis of the 
Adda side chain interacting with a hydrophobic pore of the phosphatases while the rest of the microcystin acts as a scaffold to help stabilize the 
interdigitation of the Adda with additional intermolecular interactions. 
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1. Introduction 
Cyanobacteria, so called water blooms, occur world- 
wide in mass in eutrophic fresh and brackish waters. 
Many of these water blooms are toxic, causing the death 
of fish, birds, wild animals and agricultural ivestock and 
a health risk to human beings, thus leading to a serious 
problem for water management and public health [l-6]. 
Two main types of toxins are produced by cyano- 
bacteria: peptide hepatotoxins and alkaloid neurotoxins 
[7-91. The hepatotoxins are cyclic heptapeptides, named 
microcystins, which have been recognized as potent in- 
hibitors of protein phosphatases 1 and 2A [lo-121. As 
both phosphatases play key roles in cell division, their 
inactivation should lead to tumor promotion and indeed 
microcystins were found to promote hepatic tumors initi- 
ated by diethylnitrosamine in rats [13,14]. The three- 
dimensional (3D) structures of microcystins will facili- 
tate the elucidation of the molecular mechanism of 
phosphatase inhibition. 
As shown in Fig. I, the chemical structure of microcys- 
tins corresponds to the cyclic heptapeptide cycle-(D- 
Ala’ -X2 - D - Me - iso - Asp3 -Y4- Adda’ -D-iso-Glu6-Mdha’-) 
where X and Y are variable L-amino acids, Adda the 
unusual b-amino acid (2S,3S,8$9S)-3-amino-9-methoxy- 
2,6,8-trimethyl-IO-phenyldeca-4,6-dienoic a id, Mdha 
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Abbreviations: The two variable L-amino acids present in the microcys- 
tin sequences are used to specify the toxins by single capital letter codes 
U51. 
the N-methyl-dehydroalanine and D-Me-Asp the D- 
erythro$?-methyl-aspartic a id [ 151. Additionally the two 
acidic amino acids D-Glu and D-Me-Asp are iso-linked. 
Over 40 variants of the microcystin have been isolated 
and their chemical composition characterized ([ 161 and 
references therein). In addition to the variable L-amino 
acids, common differences include demethylation of 
amino acids 3 and/or 7 [I 7,181. Among all the variants 
the most abundant, and correspondingly the best stud- 
ied, is microcystin LR. Recently we succeeded in the 
identification and structure determination of an LY var- 
iant in which the basic Arg residue is replaced by the 
aromatic Tyr [19]. This modification adjacent to the 
Adda residue, the essential component for hepatotoxicity 
[20,21], significantly lowered, but did not abolish, the 
bioactivity [22]. Thus, a comparative conformational 
analysis of these two microcystins may allow insight into 
the structural requirements for the toxicity of the micro- 
cystins. 
2. Materials and methods 
The microcystins LR and LY were obtained from J.T. Wu, Academia 
Sinica, Nankang, Taipei, and were fully characterized in terms of ho- 
mogeneity and chemical structure [19]. 
NMR spectra were measured on a Bruker AM500 spectrometer at 
300 K; the data were processed on a Bruker X32 computer with 
UXNMR software. The samples containing I mg peptide/ ~1 
DMSO-d, were prepared in 5 mm tubes. For each peptide ‘H, phase- 
sensitive TOCSY [23,24], DQF-COSY [25], NOESY [26] and ROESY 
[27] were recorded using standard pulse sequences and the following 
parameters. ID-‘H NMR (64 acquisitions, size 32K, sweep width 
6250 Hz). TOCSY (microcystin LR: size 2K, mixing time for MLEVI7 
40 ms, 96 acquisitions, 800 increments, sweep width in F, and Fz 5000 
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Hz; microcystin LY: size 2K, mixing time for MLEV17 60 ms, 96 
acquisitions, 1024 increments, sweep width in F, and F, 6250 Hz). 
NOESY (microcystin LR: size 2K, mixing time 200 ms, sweep width 
in F, and F, 5000 Hz, 64 acquisitions, 600 increments; microcystin LY: 
size 2K, mixing time 200 ms, sweep width in F, and F, 6250 Hz, 64 
acquisitions, 600 increments). DQF-COSY (microcystin LY in DMSO- 
d,: size 2K, sweep width in F, and F, 6250 Hz, 128 acquisitions, 1024 
increments; microcystin LY in DMSO-dJND,ID,O: size 2K, sweep 
width in F, and Fz 6250 Hz, 64 acquisitions, 600 increments); ROESY 
(microcystin LR: size 2K, mixing time 100 ms, 4 kHz spin lock field, 
32 acquisitions, 800 increments, sweep width in Fl and F2 6250 Hz; 
microcystin LY: size 2K, mixing time 100 ms, 4 kHz spin lock field, 64 
acquisitions, 800 increments, sweep width in Fl and F2 6250 Hz). Prior 
to transformation of the TOCSY, NOESY and ROESY spectra gauss- 
ian window functions in F, and shifted sine-bell functions in F, were 
used. Shifted sine-bell function in F, and no window function in F, were 
applied prior to transformation of both DQF-COSY spectra. The 
NOESY spectra with 200 ms mixing time were used for integration of 
NOE crosspeaks which were translated into interproton distances after 
calibration by a rm6 correlation (two spin approximation + 5%). The 
distances of pseudoatoms were corrected by adding 0.9 8, for methylen, 
1.0 I?f for methyl groups and 2.0 A for aromatic protons to the lower 
distance value. The ROESY spectra were applied for distinguishing 
ROE and chemical exchange. _ 
. _ 
From high aualitv ZD-TOCSY and DOF-COSY soectra all of the 
amino acids 0; the microcystin LR and LY were unambiguously as- 
signed (for the chemical shifts see [19]). The sequential assignment of 
both cyclic peptides was derived from the connectivities in the NH-CaH 
region of NOESY spectra, and the iso-linkage of D-Me-Asp and D-Glu 
confirmed by NOESY spectra and by DQF-COSY experiments as a 
function of pD [19]. Moreover, the (4E,6E) configuration of the double 
bond in the Adda residue was proven by the 2D-NOESY spectra, as 
stereogenic variations at this center are known to produce non-toxic 
agents [20,21]. 
The 3D structures of the cyclic peptides were determined by distance 
geometry calculations using a homewritten FORTRAN program which 
utilizes the random metrization method described by Have1 [28]. An 
all-atom representation was used, except for the CBH2 and CyH2 
methylenes of o-iso-Glu and Arg (for microcystin LR) which could not 
be diastereotopically assigned. The NOE intensities were converted to 
distances using a reference distance of 1.78 A for the iso-Glu B/j? cross 
peaks. For the computations 64 (30 intraresidue, 21 sequential and 13 
long range) and 70 (46 intraresidue, 15 sequential and 9 long range) 
NOE-derived distance constraints were used for the microcystin LY 
and LR, respectively. One hundred structures were generated from the 
distance matrices containing the holonomeric and experimental dis- 
tances. The structures were first generated in four dimensions, opti- 
mized using the distance driven dynamics method [29], reduced to 
three-dimensions using the EMBED algorithm [30] and then optimized 
again. The optimization of the structures, in both four and three dimen- 
sions were carried out in two steps of(i) 100 ps at a temperature of 1000 
K with tight coupling to a temperature bath [31] and (ii) 50 ps with a 
weak coupling to a temperature bath of 1 K, to allow for slow removal 
of the kinetic energy. 
A comparison of the pairwise rmsd values for the structures ofmicro- 
cystin LR with the smallest distance restraint violations clearly indicate 
three distinct conformational families. The three families, shown in Fig. 
2, have an average distance restraint violation of 0.16 A. The structures 
within each family have rmsd of 0.87 A and 0.30 A (family A), 0.95 8, 
and 0.57 A (family B) and 0.89 8, and 0.23 8, (family C), for all heavy 
atoms and backbone heavy atoms, respectively. For microcystin-LY, 
10 structures with the smallest distance violations were chosen for 
further analysis and are shown in Fig. 3. The average distance restraint 
violation for this final set of structures is 0.2 A. The pairwise root-mean- 
square deviations (rmsd) for all heavy atoms and backbone heavy 
atoms are 0.9 and 0.2 A, respectively. 
3. Results and discussion 
The three families of structures of microcystin LR 
exhibit a common general feature consisting of a com- 
pact planar array of the peptide backbone of Adda’+- 
iso-Glu6-Mdha’ ring portion (Fig. 4). In family A, D-Ala’ 
lies in this plane with Leu*-D-Me-Asp3 protruding from 
the plane and with Arg4 located at the edge of the plane. 
In family B Arg4 lies in the plane and Ala’ at the edge, 
while in family C Arg4 becomes part of the protrusion 
and Leu2 moves to the edge at the opposite side. Thus, 
the three families differ mainly in small movements of the 
residues which protrude from the plane formed by resi- 
dues 5-7. In this context it is noteworthy that nodularin, 
a hepatotoxic cyclic pentapeptide, isolated from the blue 
green algae Nodularia spumigena of brackish water, cor- 
responds to residues 3-7 of microcystin LR with replace- 
ment of Mdha by a-(methylamino)dehydrobutyric acid 
[32,33], thus lacking the D-Ala]-Leu2 of the microcystins. 
Since microcystin LR and nodularin have identical hepa- 
totoxicity and binding affinity to protein phosphatases 
1 and 2A [lo-121, we propose that the dipeptide sequen- 
tial intron in the microcystins (D-Ala-Leu) must adopt a 
conformational exon to maintain the correct topological 
array of the rest of the ring structure, responsible for the 
selective recognition by the receptor molecules. The 
backbone structures of microcystin LR obtained in the 
present study are in contrast to those proposed from 
modeling studies which predicted a planar ring [34,35]. 
In all three families of structures the Adda side chain, 
which is essential for hepatotoxicity [20,21], is protrud- 
ing above the main plane, distant from the sequentially 
adjacent Arg side chain (see Fig. 4). The Adda side chain, 
despite restricted rotational freedom because of double 
bonds, retains sufficient conformational space for rela- 
tively large movements (i.e. in family A the side chain is 
bent over the ring structure and in family B it is directed 
away from the ring, an effect even more pronounced in 
family C). Conversely, in the 3D structure of microcystin 
LY, as shown in Fig. 5, a surprisingly restricted confor- 
mational space is observed for the Adda side chain, most 
probably as a result of a hydrophobic collapse-type in- 
teraction with the adjacent Tyr side chain. This strong 
interaction leads to movements in the peptide backbone 
ring structure which adopts a boat-type array signifi- 
cantly different from the half-chair-like array in the LR 
variant. The aromatic interaction between the side 
chains of Tyr and Adda may explain the lower toxicity 
of this microcystin compared to that of the LR variant. 
The disruption of this hydrophobic core would be ac- 
companied by a large enthalpic cost, and therefore by a 
lower affinity for the protein phosphatases. This would 
counteract the enhancement of hepatotoxicity that 
would be predicted based on the higher hydrophobicity 
of the microcystin LY [16]. 
Okadaic acid, a fatty acid polyketal from marine 
sponges, is also known to inhibit protein phosphatases 
1 and 2A with high selectivity and potency (see [36] for 
review). The identical selectivity as microcystins strongly 
suggests identical binding sites. However, adaptation of 
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Fig. 1. Structure of microcystin LY, replacement of L-Tyr by L-Arg leads to the structure of microcystin LR. 
microcystin-LR 
Mdha Mdha 
(4 @I (C) 
Fig. 2. Superposition of the most convergent microcystin LR structures subdivided in the three conformational families A. B and C 
this large polyketal to the hypothetical binding portion 
of microcystins is difficult. The carboxylic moiety of oka- 
daic acid could mimic the a-carboxyl function of the 
invariant D-iso-Glu and wrapping around the small pla- 
nar structure of microcystin LR could introduce the op- 
posite end into the hydrophobic cavity. 
Cyclosporin A is known to prevent the hepatotoxicity 
of microcystins [37,38], but pharmacodynamic studies 
indicate that the observed effect is most probably associ- 
ated with the hepatocellular uptake mediated by the 
multispecific transport system for bile acids, since micro- 
cystin uptake can be inhibited by antamanide and ri- 
fampicin. Although cyclosporin A is a cyclic undecapep- 
tide containing mostly N-methylated amino acids and 
the unnatural, unsaturated, hydrophobic amino acid 
(4R)-4-[(E)-2-butenyl]-4,N-dimethyl-L-threonine, look- 
ing for structure similarities to account for the observed 
sharing of some membrane transport and cytosol effec- 
tor mechanism is certainly speculative. 
To conclude, from the 3D structures of the two micro- 
cystins in solution it is compelling to propose a tight 
Fig. 3. Superposition of the 10 microcystin LY structures with the 
smallest distance violations. 
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microcystin-LR 
Adda 
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Fig. 4. Superposition of the backbone atoms and the Mdha residue of 6 (family A), 6 (family B) and 5 (family C) structures of microcystin LR including 
the side chains of one conformer, respectively. 
interdigitation of the Adda side chain with a hydropho- 
bic cavity of the protein phosphatases 1 and 2A. How- 
ever, since this amino residue alone [39] or linear micro- 
cystin-related precursor peptides are not toxic [40], it is 
reasonable to assume that the remainder of the peptide 
(the planar ring portion) plays an important role in rec- 
ognition or maintaining the proper orientation for the 
Adda residue. This inhibition mechanism will certainly 
remain only a working hypothesis until the first 3D 
microcystin-LY 
Fig. 5. Superposition of the backbone atoms and the Mdha residue of 
10 microcystin LY structures including the side chains of one con- 
former. 
structure of the protein phosphatase/microcystin com- 
plex becomes available. Preliminary crystallization data 
have recently been reported for the phosphatase PPl/ 
microcystin LR complex [41]. 
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